BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), a company focused on developing and commercializing software-based medicines called prescription digital therapeutics ...

Pear Therapeutics’ search for a buyer has yet to lead to a consummated deal, and the beleaguered digital therapeutics company is now looking to auction off the business or its assets under the ...

Pear Therapeutics filed for Chapter 11 bankruptcy, according to a Friday filing with the Securities and Exchange Commission. The digital therapeutics company laid off 170 employees, the majority of ...

Pear Therapeutics, which planted some of the earliest seeds that prescription smartphone apps could stand alongside prescription drugs, has failed to bear fruit. The company filed for Chapter 11 ...

The burgeoning field of digital therapeutics was struck a blow today when Boston-based Pear Therapeutics, one of the pioneers of the space, declared Chapter 11 bankruptcy. "Today is a difficult day ...

Pear Therapeutics filed for Chapter 11 bankruptcy protection Friday and said it has eliminated most of its workforce. The filing, in bankruptcy court in Delaware, comes just three weeks after the ...

Editor's note: This story has been updated with additional information from a filing with the Securities and Exchange Commission. Pear Therapeutics, maker of prescription digital therapeutics, ...

Medical-technology company Pear Therapeutics Inc. on Friday said it has filed for chapter 11 bankruptcy with plans to sell its assets through a court-supervised auction process. The Boston developer ...